Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for KEQU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
April 30, 2026 2.866M
January 31, 2026 2.866M
October 31, 2025 2.866M
July 31, 2025 2.865M
April 30, 2025 2.839M
January 31, 2025 2.872M
October 31, 2024 2.872M
July 31, 2024 2.872M
April 30, 2024 2.839M
January 31, 2024 2.875M
October 31, 2023 2.902M
July 31, 2023 2.904M
April 30, 2023 2.83M
January 31, 2023 2.83M
October 31, 2022 2.83M
July 31, 2022 2.829M
April 30, 2022 2.79M
January 31, 2022 2.79M
October 31, 2021 2.79M
July 31, 2021 2.79M
April 30, 2021 2.763M
January 31, 2021 2.763M
October 31, 2020 2.759M
July 31, 2020 2.759M
April 30, 2020 2.751M
Date Value
January 31, 2020 2.751M
October 31, 2019 2.75M
July 31, 2019 2.75M
April 30, 2019 2.747M
January 31, 2019 2.744M
October 31, 2018 2.744M
July 31, 2018 2.741M
April 30, 2018 2.733M
January 31, 2018 2.725M
October 31, 2017 2.721M
July 31, 2017 2.713M
April 30, 2017 2.712M
January 31, 2017 2.712M
October 31, 2016 2.71M
July 31, 2016 2.698M
April 30, 2016 2.685M
January 31, 2016 2.685M
October 31, 2015 2.681M
July 31, 2015 2.63M
April 30, 2015 2.63M
January 31, 2015 2.629M
October 31, 2014 2.627M
July 31, 2014 2.623M
April 30, 2014 2.619M
January 31, 2014 2.617M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Enovis Corp. 57.67M
Edwards Lifesciences Corp. 576.60M
Intuitive Surgical, Inc. 353.90M
STAAR Surgical Co. 50.12M
Stryker Corp. 383.57M